4.7 Article

The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones

Journal

PHARMACOLOGICAL RESEARCH
Volume 175, Issue -, Pages -

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2021.106032

Keywords

Xanthones; Garcinia mangostana; Mangosteen; Chemoprevention; Anticancer; Prostate cancer

Funding

  1. National Institutes of Health [R37 CA227101]
  2. NCI [T32CA057699]

Ask authors/readers for more resources

The purple mangosteen is a popular fruit in Southeast Asia that contains xanthones, which have significant anti-cancer and anti-tumor activities. Alpha-mangostin, the most abundant xanthone, has been extensively studied for its anticancer effects, while other xanthones and mangosteen extracts also show promise but their mechanisms of action are not well understood. Clinical anticancer activity of mangosteen products has not been evaluated.
The purple mangosteen (Garcinia mangostana) is a popular Southeast Asian fruit that has been used traditionally for its health promoting benefits for years. Unique to the mangosteen are a class of phytochemicals known as xanthones that have been reported to display significant anti-cancer and anti-tumor activities, specifically through the promotion of apoptosis, targeting of specific cancer-related proteins, or modulation of cell signaling pathways. alpha-Mangostin, the most abundant xanthone isolated from the mangosteen, has received substantial attention as it has proven to be a potent phytochemical, specifically as an anticancer agent, in numerous different cancer cell studies and cancer animal models. While the mechanisms for these anticancer effects have been reported in many studies, lesser xanthones, including gartanin, beta-mangostin, gamma-mangostin, garcinone C, and garcinone E, and mangosteen extracts from the pericarp, roots, rind, and stem show promise for their anticancer activity but their mechanisms of action are not as well developed and remain to be determined. Mangosteen products appear safe and have been well tolerated in human clinical trials where they show antioxidant activity, though their clinical anticancer activity has not yet been evaluated. This review summarizes the work that has been done to explore and explain the anticancer and antitumor activities of alpha-mangostin, lesser xanthones, and mangosteen extracts in vitro, in vivo, and in humans in various cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available